Issue 91, 2022

Dinuclear osmium complexes as mitochondrion-targeting antitumor photothermal agents in vivo

Abstract

Four dinuclear osmium complexes have been constructed for antitumor phototherapy. The most potent Os4 has extremely high photothermal conversion capability under irradiation of an 808 nm low-power laser, targets mitochondria in human melanoma cells without nucleus affinity, and acts as an antitumor photothermal therapy agent in vitro and in vivo.

Graphical abstract: Dinuclear osmium complexes as mitochondrion-targeting antitumor photothermal agents in vivo

Supplementary files

Article information

Article type
Communication
Submitted
23 Sep 2022
Accepted
17 Oct 2022
First published
18 Oct 2022

Chem. Commun., 2022,58, 12676-12679

Dinuclear osmium complexes as mitochondrion-targeting antitumor photothermal agents in vivo

M. Wang, Y. Deng, Q. Li, S. Tang, R. Yang, R. Zhao, F. Liu, X. Ren, D. Zhang and F. Gao, Chem. Commun., 2022, 58, 12676 DOI: 10.1039/D2CC05230J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements